Certolizumab pegol (Certolizumab) is a polyethylene glycolated and humanized anti-TNF-alpha monoclonal antibody for the study of autoimmune diseases such as rheumatoid arthritis (RA), psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA).
Purity:
96.50%
CAS Number:
[428863-50-7]
Target:
TNF
* VAT and and shipping costs not included. Errors and price changes excepted